BoYen Therapeutics, Inc.

BoYen Therapeutics has a product pipeline with abundance of commercial value. BY-101 is an USFDA designated orphan drug with 7-year period marketing exclusivity. BY-101 is intended for the treatment of acute myeloid leukemia (AML), and will enter Phase 2/3 clinical trials through USFDA 505(b)2 pathway in 2021.BY-102, BY-103 and BYT-3156 are patented drug candidates for the treatment of multiple sclerosis, leukemia, pancreatic cancer, colorectal cancer, lung cancer, breast cancer and other indications.

BoYen Therapeutics, Inc.

BoYen Therapeutics has a product pipeline with abundance of commercial value. BY-101 is an USFDA designated orphan drug with 7-year period marketing exclusivity. BY-101 is intended for the treatment of acute myeloid leukemia (AML), and will enter Phase 2/3 clinical trials through USFDA 505(b)2 pathway in 2021.BY-102, BY-103 and BYT-3156 are patented drug candidates for the treatment of multiple sclerosis, leukemia, pancreatic cancer, colorectal cancer, lung cancer, breast cancer and other indications.

Brain Navi Biotechnology Co., Ltd.

NAoTrac, the surgical navigation robot, merges high-precision technology and the experience of surgeons to improve accuracy and outcome by streamlining surgical procedures and improving the learning curve equipped with AI, Machine Vision, and Robot-assisted surgery.
Fast and precise navigation with non-contact registration, pre-operating planning preparation, choosing the surgery pathway with 3D vision for precise anatomical location. The unique autonomous procedure allows the surgeon to plan and let NaoTrac act as his assistant.

Braster S.A.

Our mission is to create a healthier world. We want to achieve this by reaching women around the world and providing them with the opportunity to perform a non-invasive, inexpensive and reliable breast examination. Our device is available for home use as well as for professional use. It is an innovative method of prophylactic breast examination which complements standard ultrasound and mammography scans.

BriteMED Technology

BriteMED is manufacturing and marketing medical devices and electronic medical solutions that improve patient care, covering 12-lead ECG, medical monitor, medical all-in-one, medical workstation, and telehealth workstations.

BROADSIMS Inc.

AVS® AI-based verification system provides verification solution for medical electrical equipment including 12 lead ECG, patient monitors, ECG wearables and oximeters etc. For manufacturers, 3rd party testing labs or hospitals, conventional testing/verification methods of the above-mentioned devices rely on huge manual operation and judgment and this triggers quality and correctness concerns. Accordingly, BROADSIMS Inc. creates an AI-based verification system AVS® to perform screen and image recognition, transferring manual work to full automation. AVS compares test results with regulation and standards (e.g. IEC, YY, JJG) and generates electronic reports automatically, then reports are all stored in a database. Whole process saves time and complies with medical regulation.

bzcasa

Electric massage table